The prison agency in the nation's busiest death penalty state paid $13,500 for its most recent batch of pentobarbital at a cost of $1,500 per vial, compared to $350 per dose spent last year.
Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty...
A freeze on capital punishment in Ohio will continue into 2015 after a federal judge extended a...
The wealthy businessman who lavished former Virginia Gov. Bob McDonnell and his wife with...
McKesson Corp. was required to ensure vaccines were maintained at proper temperatures by, among other things, setting electronic temperature monitors to detect when air temperature in the box reached certain levels.
Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers. While the issue applies broadly to all patients with chronic illnesses that require expensive medication, HIV and AIDS advocates say they were the first to file a formal complaint with the government about pricing.
Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, Inc., has entered into settlement and license agreements with Fresenius Kabi USA, LLC, resolving pending patent litigation involving OFIRMEV ® (acetaminophen) injection.
Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses. The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Chinese regulators have launched a series of anti-monopoly investigations of foreign automakers and technology providers, stepping up pressure on foreign companies that feel increasingly unwelcome in China.
Federal investigators warn of the growing problem of "dirty doctors," who prescribe highly-addictive painkillers for cash.
Allergan Inc.'s lawsuit, filed Friday in U.S. District Court in Santa Ana, California, names as plaintiffs drugmaker Valeant Pharmaceuticals International Inc., New York investment and hedge fund firm Pershing Square Capital Management LP and its principal, William Ackerman.
Bob McDonnell headed back to court Thursday over federal corruption charges alleging that he and his wife accepted more than $165,000 in gifts, lavish trips, and cash in exchange for promoting dietary supplements.
Idaho prison officials say they had to have thousands of dollars' worth of medications shipped overnight to the state's largest prison after the former operator, Corrections Corporation of America, left the facility without a promised eight-day supply of inmate drugs.
A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens. The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial."
A third execution by lethal injection has gone awry in six months, renewing debate over whether there is a foolproof way for the government to humanely kill condemned criminals, and whether it's even worth looking for one.
Staking out a populist stand ahead of the midterm elections, President Barack Obama on Thursday demanded "economic patriotism" from U.S. corporations that use legal means to avoid U.S. taxes through overseas mergers.
Humans are a strange lot. We are more than willing to believe just about any product claim in the hopes that an easy solution to our problem can be found inside a pill, tablet or liquid.
The Oregon lawsuit filed Thursday in Portland contends 5-Hour Energy falsely claims customers get extra energy and focus from a unique blend of ingredients, when the boost actually comes from a concentrated dose of caffeine.
Chinese authorities formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information, state media reported Monday. Prosecutors in Shanghai filed charges against British investigator Peter Humphrey and his wife Yingzeng Yu, a U.S. citizen, at the city's No. 1 Intermediate People's Court, the official Xinhua News Agency said.
Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies.
Neurelis has announced an agreement with Biotie Therapies to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 for pediatric and adult epilepsy patients who experience acute repetitive seizures.
A pharmacist who oversaw a major hospital's vault of drugs stole nearly 200,000 powerful painkillers he was supposed to safeguard and dispense, narcotics prosecutors said Tuesday as they unveiled a case that makes unusual use of a state drug-kingpin law.
The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.
A U.S. Embassy spokesman says diplomats are barred from the trial in Shanghai of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information. Spokesman Nolan Barkhouse said Friday that the U.S. government is concerned about lack of access to the trial of Yu Yingzeng and husband Peter Humphrey in August.
Dong-Pyou Han, 57, entered his not guilty pleas to four counts of making false statements during his initial court appearance in Des Moines federal court. Each count carries a maximum sentence of five years in prison and a $250,000 fine.
The Supreme Court ruled Monday that some corporations can hold religious objections that allow them to opt out of the new health law requirement that they cover contraceptives for women. The justices' 5-4 decision is the first time that the high court has ruled that profit-seeking businesses can hold religious views under federal law.
The Supreme Court is poised to deliver its verdict in a case that weighs the religious rights of employers and the right of women to the birth control of their choice. The court meets for a final time Monday to release decisions in its two remaining cases before the justices take off for the summer.
Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.
Pershing Square, the investment firm run by activist investor Bill Ackman, said Friday it settled a lawsuit with Allergan, the maker of Botox, related to Allergan's poison pill plan and Pershing's $53 billion offer for the company.
- Page 1